Regenerative medicine (RM) is one of the most promising fields of regenerative medicine, with regenerative ophthalmology (RO) being one of the most active domains. The ability of revolutionary therapies to treat a number of disorders, ranging from AMD to congenital degenerations, is being explored. Regenerative ophthalmology (RO) strives to restore function by employing biomaterials, cells, and bioactive substances to replace or regenerate tissues and organs. These unique therapeutic techniques have the potential to improve the effectiveness and efficiency of ocular disease management. With the advancement of tissue engineering tools, RO researchers have focused their attention on the regeneration of lost or injured eye tissues as a new way to cure visual impairment and blindness caused by ocular degenerative disorders, trauma, or infection.
Title : Rare and interesting case of Goldenhar’s syndrome in a 3 years old male child
Gowhar Ahmad, Florence Hospital Srinagar, India
Title : Management of common vitreoretinal lesions: An overview and update
Tim Jackson, King’s College London, United Kingdom
Title : Lumevoq gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : Targeting immunological pathways in Behcet's Uveitis
Hashim Butt, Bolton Royal Hospital, United Kingdom
Title : An advanced 3D human-based in vitro model to identify disease-specific molecular markers of glaucoma neurodegeneration
Anna Maria Bassi, University of Genoa, Italy
Title : Evaluating the quality and readability of AI chatbot responses to frequently asked questions on basal cell carcinoma: Implications for patient education and digital health communication
Arrane Selvamogan, Leicestershire Partnership NHS Trust, United Kingdom